Compliance Certificate under Regulation 74(5) for the quarter ended 30th June, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ending 30th June 2025. This is a routine regulatory filing submitted by the company's Registrar and Share Transfer Agent (RTA) to confirm that all share certificates received for dematerialization (conversion from physical to electronic form) during the quarter were properly processed, mutilated, and cancelled, with corresponding demat credits issued to shareholders. There are no financial figures, transactions, or corporate actions involved in this filing.
This is a standard regulatory compliance submission with no material impact on the company's financials, operations, or share price. It is a routine housekeeping requirement and does not signal any positive or negative development for shareholders.